Long-term effects of angiopeptin treatment in coronary angioplasty: reduction of clinical events but not angiographic restenosis.
Serruys
P W
PW
D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects*; D002317:Cardiovascular Agents / Q000627:therapeutic use*; D017023:Coronary Angiography; D003327:Coronary Disease / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D009842:Oligopeptides / Q000627:therapeutic use*; D010456:Peptides, Cyclic; D013004:Somatostatin / Q000031:analogs & derivatives* / Q000627:therapeutic use
D002317:Cardiovascular Agents; D009842:Oligopeptides; D010456:Peptides, Cyclic; C060347:lanreotide; D013004:Somatostatin